Last reviewed · How we verify
NCT03041961
Aronia Berry Consumption on Vascular Function
NA trial testing Placebo in Healthy Young Men in 66 participants. Completed in 20 July 2017.
20 July 2017
Quick facts
| Lead sponsor | King's College London |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 66 |
| Start date | 14 February 2017 |
| Primary completion | 20 July 2017 |
| Estimated completion | 20 July 2017 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Placebo
- Aronia full spectrum
- Aronia extract
Conditions studied
- Healthy Young Men — all drugs for Healthy Young Men →
Sponsor
King's College London
Who can join
Adults 18 to 45, male only, with Healthy Young Men. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is an increasing interest in the effects of various food derived polyphenols on vascular function. Arguably the most well-established vascular benefits are attributed to flavanols from cocoa beans and this has been supported by a successful health claim through the European Food Safely Authority in 2012. Berry fruits are another rich source of polyphenols that have vasoactive properties, and there is a growing body of research exploring these effects in various berries (blueberries, cranberries, strawberries) and other fruit products with similar polyphenol composition. A key (poly)phenol in berries and other fruits believed to provide much of the benefit is anthocyanins. When given as an isolated extract, 320 mg anthocyanins have been found to improve blood vessel function both acutely and in response to chronic consumption over 12 weeks. Aronia berries are a native North American berry with high naturally occurring anthocyanins among other polyphenols. Based on their polyphenol composition, there is growing interest in the potential for Aronia berries to elicit health promoting cardio-metabolic effects. Specifically, Aronia berry extracts, which provide a concentrated source of polyphenols, may improve blood vessel function. Thus, the primary focus of this project is to evaluate the effects of Aronia berry extracts of differing polyphenol dose on vascular endothelial function.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effects of aronia berry (poly)phenols on vascular function and gut microbiota: a double-blind randomized controlled trial in adult men.
Istas G, Wood E, Le Sayec M, Rawlings C, et al · · 2019 · cited 91× · PMID 31152545 · DOI 10.1093/ajcn/nqz075 -
Consumption of Stilbenes and Flavonoids is Linked to Reduced Risk of Obesity Independently of Fiber Intake.
Mompeo O, Spector TD, Matey Hernandez M, Le Roy C, et al · · 2020 · cited 25× · PMID 32585900 · DOI 10.3390/nu12061871 -
Development of a (Poly)phenol Metabolic Signature for Assessing (Poly)phenol-Rich Dietary Patterns.
Li Y, Xu Y, Le Sayec M, Yan X, et al · · 2024 · cited 6× · PMID 38829321 · DOI 10.1021/acs.jafc.4c00959 -
Development of metabolic signatures of plant-rich dietary patterns using plant-derived metabolites.
Li Y, Xu Y, Sayec ML, Spector TD, et al · · 2024 · cited 2× · PMID 39604558 · DOI 10.1007/s00394-024-03511-x
Verify or expand the search:
- PubMed search for NCT03041961
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other King's College London trials
Trials by the same sponsor.
- NCT07357064 — Professional Decision Making in Childbirth. · not yet recruiting
- NCT07341087 — Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial · NA · recruiting
- NCT07228962 — Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies · not yet recruiting
- NCT07365722 — Comparison of Two Non-surgical Procedure to Manage Gum Disease Around Implants. · NA · not yet recruiting
- NCT07378488 — Dance/Movement Therapy for Functional Neurological Disorder · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03041961 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King's College London
- Last refreshed: 5 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03041961.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing